- Home
- ARVN vs CAKE Comparison
ARVN vs CAKE Comparison
Compare ARVN & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CAKE
- Stock Information
- Founded
- ARVN 2015
- CAKE 1972
- Country
- ARVN United States
- CAKE United States
- Employees
- ARVN N/A
- CAKE N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CAKE Restaurants
- Sector
- ARVN Health Care
- CAKE Consumer Discretionary
- Exchange
- ARVN Nasdaq
- CAKE Nasdaq
- Market Cap
- ARVN 1.7B
- CAKE 2.0B
- IPO Year
- ARVN 2018
- CAKE 1992
- Fundamental
- Price
- ARVN $25.76
- CAKE $42.45
- Analyst Decision
- ARVN Strong Buy
- CAKE Hold
- Analyst Count
- ARVN 15
- CAKE 14
- Target Price
- ARVN $57.50
- CAKE $40.85
- AVG Volume (30 Days)
- ARVN 487.9K
- CAKE 935.1K
- Earning Date
- ARVN 10-30-2024
- CAKE 10-29-2024
- Dividend Yield
- ARVN N/A
- CAKE 2.54%
- EPS Growth
- ARVN N/A
- CAKE 82.87
- EPS
- ARVN N/A
- CAKE 2.39
- Revenue
- ARVN $93,300,000.00
- CAKE $3,502,484,000.00
- Revenue This Year
- ARVN $179.49
- CAKE $6.24
- Revenue Next Year
- ARVN N/A
- CAKE $5.72
- P/E Ratio
- ARVN N/A
- CAKE $17.73
- Revenue Growth
- ARVN N/A
- CAKE 2.74
- 52 Week Low
- ARVN $13.57
- CAKE $29.27
- 52 Week High
- ARVN $53.08
- CAKE $43.41
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- CAKE 60.46
- Support Level
- ARVN $25.42
- CAKE $38.47
- Resistance Level
- ARVN $29.24
- CAKE $43.41
- Average True Range (ATR)
- ARVN 1.24
- CAKE 1.21
- MACD
- ARVN 0.18
- CAKE 0.20
- Stochastic Oscillator
- ARVN 34.71
- CAKE 80.84
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.